American Heart Association

NT-proBNP is more predictive of unfavorable outcomes in HFpEF in the absence of AFib

Contributor: Martin Chacon

Does an increased NT-proBNP in patients with atrial fibrillation (AF) and HFpEF correspond to a higher risk for worse outcomes? Kristensen et al suggest increased NTproBNP levels do not show the same correlation with poor outcomes in patients with AF compared with those without AF. NT-proBNP is increased in AF patients independently from heart failure, therefore, its capacity to predict cardiovascular death or hospitalizations in HFpEF may be diminished.

Hemodynamic Ramp Testing For More Accurate HVAD Tuning

Contributors: Ike Chinyere and Michela Brambatti

Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes The RAMP-IT-UP Multicenter Study

Study Link: Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes: The RAMP-IT-UP Multicenter Study

Visual Abstract: Cardiac Troponin I and Cardiac Events in HFpEF Patients

Contributor: Ike Chinyere

Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction

Study Link: Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection Fraction

Visual Abstract: Pulmonary Production of ST2

Contributor: Ike Chinyere

Pulmonary Production of Soluble ST2 in Heart Failure

Study Link: Pulmonary Production of Soluble ST2 in Heart Failure

Visual Abstract: Psychosocial Assessment Before LVAD Implantation

Contributor: Darien Allen

Standardized Psychosocial Assessment Before Left Ventricular Assist Device Implantation: An Important Predictive Measure

Study Link: Standardized Psychosocial Assessment Before Left Ventricular Assist Device Implantation: An Important Predictive Measure